Press releaseGlobe Newswire
Tonix Pharmaceuticals Holding
TNXP · NASDAQ
$5.78+$0.11 (+1.94%)TodayMarket closed ·
Prev close $5.67
Latest news
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
- NewsDylan Berman
Tonix Shares Jump After Landing Second Commercial Payer Agreement For TONMYA
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Participate in Two Investor Conferences in May
- NewsDylan Berman
Why Tonix Pharmaceuticals Shares Are Rallying Wednesday
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
- NewsHenry Khederian
Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsVandana Singh
Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Participate in Two Investor Conferences in March
- NewsVandana Singh
Tonix Unveils Once-Yearly Lyme Prevention Antibody, Eyes FDA Talks In 2026
- Press releaseGlobe Newswire
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
- NewsHenry Khederian
Why Tonix Pharmaceuticals (TNXP) Stock Jumped Monday Morning
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
- Press releaseGlobe Newswire
Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025
- NewsAvi Kapoor
Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsVandana Singh
Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
- NewsAvi Kapoor
Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
- NewsHenry Khederian
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
- NewsHenry Khederian
Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week
- NewsAvi Kapoor
Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
- News
World Health Organization Says MPOX Remains A Public Health Emergency Of International Concern
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsHenry Khederian
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsHenry Khederian
Why Tonix Pharmaceuticals (TNXP) Stock Is Falling
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.